The global market for Blood Bank (Blood Banking) was valued at US$ 21280 million in the year 2024 and is projected to reach a revised size of US$ 33300 million by 2031, growing at a CAGR of 6.7% during the forecast period.
A blood bank is a center where blood gathered as a result of blood donation is stored and preserved for later use in blood transfusion. The term "blood bank" typically refers to...
The global market for Custom Antibody Services was valued at US$ 2225 million in the year 2024 and is projected to reach a revised size of US$ 4137 million by 2031, growing at a CAGR of 9.4% during the forecast period.
Custom antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of ant...
The global market for First-in-Human (FIH) Services was valued at US$ 654 million in the year 2024 and is projected to reach a revised size of US$ 1298 million by 2031, growing at a CAGR of 11.3% during the forecast period.
First-in-Human Services refer to specialized services that support the planning, execution, and management of First-in-Human (FIH) clinical trials. These services are critical...
The global market for Value-added Medicines (VAM) was valued at US$ 721 million in the year 2024 and is projected to reach a revised size of US$ 1450 million by 2031, growing at a CAGR of 11.3% during the forecast period.
Value-added medicines offer the medical world the opportunity to increase the quality of treatments as well as expand access to healthcare for more people. By improving the effic...
The global market for Value-added Medicines (VAM) Development Service was valued at US$ 553 million in the year 2024 and is projected to reach a revised size of US$ 1059 million by 2031, growing at a CAGR of 10.5% during the forecast period.
Value-added Medicines Development Service usually refers to adding additional value to pharmaceutical products by providing professional technical support,...
The global market for New Chemical Entities (NCE) CDMO was valued at US$ 2614 million in the year 2024 and is projected to reach a revised size of US$ 5607 million by 2031, growing at a CAGR of 11.4% during the forecast period.
New Chemical Entities (NCE) refer to new compounds that have not yet been approved for any therapeutic use during the drug development process. These compounds are usually...
The global market for New Chemical Entities (NCE) was valued at US$ 4252 million in the year 2024 and is projected to reach a revised size of US$ 8590 million by 2031, growing at a CAGR of 11.2% during the forecast period.
During the drug discovery process, new compounds or active moieties (molecules or ions responsible for physiological or pharmacological action) can arise that have not previousl...
The global market for Niche Active Pharmaceutical Ingredients (API) and Intermediates was valued at US$ 4618 million in the year 2024 and is projected to reach a revised size of US$ 8579 million by 2031, growing at a CAGR of 9.8% during the forecast period.
The expansion of personalized medicine, coupled with the rise of precision therapies, has created a significant opportunity for niche APIs. Th...
The global market for iPSC Cell Therapies was valued at US$ 9434 million in the year 2024 and is projected to reach a revised size of US$ 19900 million by 2031, growing at a CAGR of 11.4% during the forecast period.
Induced pluripotent stem cell (iPSC) cell therapy is a cutting-edge regenerative medicine technology that uses somatic cells to be converted into pluripotent stem cells through genetic...
The global market for Targeted Drug Delivery System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Targeted Drug Delivery System is a technology used to precisely deliver drugs to specific target areas. This system is designed to increase the efficacy of the drug and reduce its impact on...
Our team would be happy to assist you with your queries.
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals